AstraZeneca PLC

AZN

Market cap$286.27 B

Rank#45

SEC filings1,004

AstraZeneca PLC trades as AZN and has a market capitalization of $286.27 B, making it the #45 largest US-listed company by market value. This page tracks AstraZeneca PLC through 1,004 SEC filings, with financial statements and metrics updated as new reports are filed.

Key metrics

Total assets (latest FY)$114.07BFY 2025

Latest filings

Filing	Type	Filed
6-K	-	2026-05-18
6-K	-	2026-05-18
6-K	-	2026-05-18
6-K	-	2026-05-14
Insider trade	4	2026-05-08
6-K	-	2026-05-01
6-K	-	2026-05-01
6-K	-	2026-05-01

Browse the full filing history (1,004 filings)

Recent press releases

Annual Report 20252026-04-03
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
Annual Report 2025
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
Annual Report 2025
Featured websiteAstraZeneca Clinical Trials Featured websiteOpen Innovation
Full Year and Q4 2025 results - AstraZeneca
We announced the results of 16 positive Phase 3 studies during the year and now have 16 blockbuster medicines. The momentum across our company ...
Astrazeneca Plans To Invest 50bn Dollars In The US

Similar companies

The largest companies sharing AstraZeneca PLC's SEC industry classification (pharmaceutical preparations).

LLYEli Lilly and Company$1.072 T AZN vs LLY

JNJJohnson & Johnson$573.98 B AZN vs JNJ

ABBVAbbVie Inc.$399.47 B AZN vs ABBV

MRKMerck & Co., Inc.$293.16 B AZN vs MRK

NVSNovartis AG$283.13 B AZN vs NVS

GSK

Frequently asked questions

What is AstraZeneca PLC's market cap?

AstraZeneca PLC (AZN) has a market capitalization of $286.27 B as of 2026-05-29, ranking #45 among US-listed companies.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.